Designer drugs: mechanism of action and adverse effects

D Luethi, ME Liechti - Archives of toxicology, 2020 - Springer
Psychoactive substances with chemical structures or pharmacological profiles that are
similar to traditional drugs of abuse continue to emerge on the recreational drug market …

[HTML][HTML] Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods

KM Lisdahl, KJ Sher, KP Conway, R Gonzalez… - Developmental cognitive …, 2018 - Elsevier
One of the objectives of the Adolescent Brain Cognitive Development (ABCD) Study
(https://abcdstudy. org/) is to establish a national longitudinal cohort of 9 and 10 year olds …

Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety

AK Davis, FS Barrett, RR Griffiths - Journal of contextual behavioral science, 2020 - Elsevier
Prior research has shown that acute subjective psychedelic effects are associated with both
spontaneous and intended changes in depression and anxiety. Psychedelics are also …

Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: Role of tryptophan metabolites generated by gut host-microbiota

A Salminen - Journal of Molecular Medicine, 2023 - Springer
Gut microbiota in interaction with intestinal host tissues influences many brain functions and
microbial dysbiosis has been linked with brain disorders, such as neuropsychiatric …

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

A Rickli, OD Moning, MC Hoener, ME Liechti - European …, 2016 - Elsevier
The present study investigated interactions between the novel psychoactive tryptamines
DiPT, 4-OH-DiPT, 4-OH-MET, 5-MeO-AMT, and 5-MeO-MiPT at monoamine receptors and …

Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants

NL Galvão-Coelho, W Marx, M Gonzalez, J Sinclair… - …, 2021 - Springer
Rationale Major depressive disorder is one of the leading global causes of disability, for
which the classic serotonergic psychedelics have recently reemerged as a potential …

Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness

J Hamill, J Hallak, SM Dursun… - Current …, 2019 - benthamdirect.com
Background: Ayahuasca, a traditional Amazonian decoction with psychoactive properties, is
made from bark of the Banisteriopsis caapi vine (containing beta-carboline alkaloids) and …

N, N-dimethyltryptamine (DMT), an endogenous hallucinogen: past, present, and future research to determine its role and function

SA Barker - Frontiers in neuroscience, 2018 - frontiersin.org
This report provides a historical overview of research concerning the endogenous
hallucinogen N, N-dimethyltryptamine (DMT), focusing on data regarding its biosynthesis …

Adolescent and adult time trends in US hallucinogen use, 2002–19: Any use, and use of ecstasy, LSD and PCP

O Livne, D Shmulewitz, C Walsh, DS Hasin - Addiction, 2022 - Wiley Online Library
Abstract Background and Aims Hallucinogen use is potentially harmful. Information on
whether such use has increased in recent decades is lacking. This study assessed overall …

Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies

RG Dos Santos, JC Bouso… - Therapeutic advances in …, 2017 - journals.sagepub.com
Ayahuasca is a hallucinogen brew traditionally used for ritual and therapeutic purposes in
Northwestern Amazon. It is rich in the tryptamine hallucinogens dimethyltryptamine (DMT) …